Navigation Links
CFO of China Yingxia Emphasizes Growth in Organic and Health Food Segment in Interview by The Wall Street Transcript
Date:10/20/2008

HARBIN, China, Oct. 20 /Xinhua-PRNewswire-FirstCall/ -- China Yingxia International, Inc. (OTC Bulletin Board: CYXI) ("China Yingxia" or "the Company"), a leading provider in the health and nutritional food industry engaged in the development, manufacture and distribution of nutritional food products, dietary supplements, and raw cactus plants in the People's Republic of China ("PRC"), today announced that the Company's Chief Financial Officer Ren Hu was interviewed by the Wall Street Transcript to discuss the Company's growth strategy involving its organic and health food business. The interview was published October 20, 2008.

In the interview, Mr. Hu stated that the demand for organic and health food in China is propelled by the increasing disposable income of Chinese urbanites, along with concerns over food safety. China Yingxia has actively focused on growing its nutritional food segment to address this demand. The recent acquisition of a soy milk production facility in Shanghai was a step in this direction, as it equipped the Company with advanced food processing technology for the production of soy milk and soy yogurt.

On addressing the recent scandal involving contaminated cow's milk in China, Mr. Hu considered it to be an opportunity for China Yingxia, since the Company's products are soybean based milk and yogurt, while the majority of the tainted products were derived from cow's milk. The Company's integrated business model and rigid quality control procedures also prevent harmful substances from entering the production process. Soy milk is believed to have more health benefits and a scandal like this may urge more consumers to look for alternatives to cow's milk. China Yingxia will start a marketing campaign to position the Company's organic and health food products attractively to the consumers.

"China Yingxia follows two main strategies to expand its market," Mr. Hu stated in the interview. "The first is to expand the distribution network by adding more stores via proper marketing campaigns and promotions. The second strategy is to grow through acquisitions to break geographical barriers."

About China Yingxia International, Inc.

China Yingxia International, Inc., through its 100%-owned subsidiary, Harbin Yingxia Industrial Group Co., Ltd. ('Yingxia'), is primarily engaged in the development, production and sales of health food products in China. Yingxia is located in the Province of Heilongjiang, Peoples Republic of China. Yingxia's products include soybean-based foods and drinks, longgu golden millet enriched products, organic rice products, raw cacti, cactus and other herbal-based supplements, cosmetics, personal care products, and Nestle products.

Safe Harbor Statement

The statements contained herein that are not historical facts are 'forward-looking statements' within the meaning of Section 21E of the Securities and Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. Such forward-looking statements may be identified by, among other things, the use of forward-looking terminology such as 'believes,' 'expects,' 'may,' 'will,' 'should,' or 'anticipates,' 'expect' or the negative thereof or other variations thereon or comparable terminology, or by discussions of strategy that involve risks and uncertainties. In particular, our statements regarding the potential growth of the markets or forecasting financial results are examples of such forward-looking statements. The forward-looking statements include risks and uncertainties, including but not limited to, general economic conditions and regulatory developments, not within our control. The factors discussed herein and expressed from time to time in our filings with the Securities and Exchange Commission could cause actual results and developments to be materially different from those expressed or implied by such statements. The forward-looking statements are made only as of the date of this filing, and we undertake no obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances.

For more information, please contact:

Company Contact:

Mr. Ren Hu

Chief Financial Officer

China Yingxia International, Inc.

Tel: +1-201-887-0415

Email: arenhu@gmail.com

Investor Relations Contact:

Mr. Crocker Coulson

President

CCG Investor Relations

Tel: +1-646-213-1915

Email: crocker.coulson@ccgir.com

Web: http://www.ccgir.com


'/>"/>
SOURCE China Yingxia International, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Waters Publishes Rapid and Specific Method of Detection for Melamine in Infant Formula and Liquid Milk, in Support of Chinas Ministry of Science and Technology
2. China Biologic Products Provides Preliminary Guidance for 2009 of Revenues of $90 to $100 Million and Net Income of $18 to 22 Million
3. China Bio Energy Holdings Group Announces Financing and Exercise of Warrants
4. China-Biotics, Inc. Retains KPMG for the Implementation of Sarbanes-Oxley Act Section 404
5. China Biologic Products Enters Into Agreement to Acquire 35% Interest in Xian Huitian Blood Products Co., Ltd. and Introduces Preliminary Guidance for 2009
6. China-Biotics, Inc. Approved to List on the Nasdaq Global Market
7. China Sky One Medical, Inc. Starts Production at Newly Acquired Facility and Reaffirms Guidance
8. China Medicine to Showcase Bethin Weight Loss Product at 2008 Natural Products Expo East Trade Show
9. China Yingxia International, Inc. Announces $2 Million Share Repurchase Program
10. China Biologic Products Enters Into Agreement to Acquire 90% Controlling Interest in Chongqing Dalin Biologic Technologies Co., Ltd.
11. WuXi PharmaTech (NYSE:WX) Maintains Original Strategy to Provide Toxicology Services in China
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... San Jose, CA (PRWEB) , ... January 17, 2017 , ... ... people cultivate a balanced, peaceful and healthy lifestyle, announced today the official launch of ... body and frees the mind. , In development for over a year, ...
(Date:1/17/2017)... 17, 2017  Protagonist Therapeutics, Inc. (NASDAQ: ... initiated a global Phase 2b induction study in ... targets alpha4beta7 integrin. The aim of this randomized, ... the safety/tolerability and efficacy of PTG-100 in approximately ... severe active disease. "We are ...
(Date:1/16/2017)... ... January 16, 2017 , ... ... prestigious Tibbetts Award from the U.S. Small Business Administration. The Tibbetts ... significant economic or social impact […] and are considered the best of the ...
(Date:1/13/2017)... 13, 2017 Research and Markets has announced ... - Global Forecast to 2021" report to their offering. ... The biosimilars market ... 3.39 Billion in 2016, at a CAGR of 26.3%. ... product, manufacturing type, and application. Factors such as rising incidence of ...
Breaking Biology Technology:
(Date:12/8/2016)... Dec. 8, 2016  Singulex, Inc., the leader in ... entered into a license and supply agreement with Thermo ... agreement provides Singulex access to Thermo Scientific BRAHMS PCT ... is used to diagnose systemic bacterial infection and ... to aid in assessing the risk of critically ...
(Date:12/7/2016)... , December 7, 2016 BioCatch , the ... of its patent portfolio, which grew to over 40 granted and pending ... , , ... filed patent entitled " System, Device, and Method Estimating Force ... enables device makers to forego costly hardware components needed to estimate the ...
(Date:12/7/2016)... , Dec. 7, 2016   Veridium ... announced the appointment of new CEO James ... executive with decades of experience, has served in ... Cisco, where he specialized in expanding a pipeline ... technology portfolios. He most recently served as managing ...
Breaking Biology News(10 mins):